Molecular mechanisms of anti-cancer bioactivities of seaweed polysaccharides

被引:0
|
作者
Tingting Liu [1 ]
Qing Li [2 ,3 ]
Xu Xu [2 ,3 ]
Guoxia Li [1 ]
Chengwang Tian [2 ,3 ,4 ]
Tiejun Zhang [2 ,3 ,4 ]
机构
[1] School of Basic Medicine, Tianjin Medical University
[2] Tianjin Pharmaceutical Research Institute
[3] State Key Laboratory of Drug Release Technology and Pharmacokinetics
[4] Research Unit for Drug Metabolism, Chinese Academy of Medical
关键词
D O I
暂无
中图分类号
R285 [中药药理学];
学科分类号
摘要
Seaweed is a traditional Chinese medicine homologous to food, in which polysaccharides are responsible for anti-cancer by enhancing immunity, inducing cancer cell apoptosis, inhibiting cancer cell invasion and metastasis or directly scavenging oxidative free radicals that induce cancer cell changes. Among them,regulating immunity and promoting cancer cell apoptosis are intensively studied due to the important role in preventing cancer. Here we reviewed seaweed in the apoptosis-inducing signaling pathways including PI3K/AKT, ROS and JNK and discussed challenges in studying seaweed.
引用
收藏
页码:528 / 534
页数:7
相关论文
共 50 条
  • [41] Sesquiterpenoid lactones as potential anti-cancer agents: an update on molecular mechanisms and recent studies
    Praveen Dhyani
    Priyanka Sati
    Eshita Sharma
    Dharam Chand Attri
    Amit Bahukhandi
    Bekzat Tynybekov
    Agnieszka Szopa
    Javad Sharifi-Rad
    Daniela Calina
    Hafiz A. R. Suleria
    William C. Cho
    Cancer Cell International, 22
  • [42] Caloric restriction - A promising anti-cancer approach: From molecular mechanisms to clinical trials
    Kopeina, Gelina S.
    Senichkin, Vyacheslav V.
    Zhivotovsky, Boris
    BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER, 2017, 1867 (01): : 29 - 41
  • [43] FGF/FGFR-Dependent Molecular Mechanisms Underlying Anti-Cancer Drug Resistance
    Szymczyk, Jakub
    Sluzalska, Katarzyna Dominika
    Materla, Izabela
    Opalinski, Lukasz
    Otlewski, Jacek
    Zakrzewska, Malgorzata
    CANCERS, 2021, 13 (22)
  • [44] Anti-cancer targets and molecular mechanisms of formononetin in treating osteosarcoma based on network pharmacology
    Chen, Lizhi
    Zhou, Yue
    Weng, Zheng
    Liu, Shuang
    Li, Ting
    Wang, Yanfang
    Yang, Yang
    Liu, Hongmei
    Huang, Wenhua
    AGING-US, 2023, 15 (20): : 11489 - 11507
  • [45] Histone deacetylase inhibitors: molecular mechanisms of action and clinical trials as anti-cancer drugs
    Kim, Hyun-Jung
    Bae, Suk-Chul
    AMERICAN JOURNAL OF TRANSLATIONAL RESEARCH, 2011, 3 (02): : 166 - 179
  • [46] Anti-cancer targets of formononetin and molecular mechanisms in osteosarcoma: Findings of bioinformatic and experimental assays
    Hu, Wei
    Wu, Xianpei
    Tang, Jiandong
    Zhao, Guoping
    Xiao, Niansu
    Zhang, Li
    Li, Sen
    JOURNAL OF CELLULAR AND MOLECULAR MEDICINE, 2019, 23 (05) : 3505 - 3511
  • [47] Sesquiterpenoid lactones as potential anti-cancer agents: an update on molecular mechanisms and recent studies
    Dhyani, Praveen
    Sati, Priyanka
    Sharma, Eshita
    Attri, Dharam Chand
    Bahukhandi, Amit
    Tynybekov, Bekzat
    Szopa, Agnieszka
    Sharifi-Rad, Javad
    Calina, Daniela
    Suleria, Hafiz A. R.
    Cho, William C.
    CANCER CELL INTERNATIONAL, 2022, 22 (01)
  • [48] Modulation of Apoptosis by Plant Polysaccharides for Exerting Anti-Cancer Effects: A Review
    Gan, Qing-xia
    Wang, Jin
    Hu, Ju
    Lou, Guan-hua
    Xiong, Hai-jun
    Peng, Cheng-yi
    Huang, Qin-wan
    FRONTIERS IN PHARMACOLOGY, 2020, 11
  • [49] Apigenin in cancer therapy: anti-cancer effects and mechanisms of action
    Yan, Xiaohui
    Qi, Miao
    Li, Pengfei
    Zhan, Yihong
    Shao, Huanjie
    CELL AND BIOSCIENCE, 2017, 7
  • [50] Apigenin in cancer therapy: anti-cancer effects and mechanisms of action
    Xiaohui Yan
    Miao Qi
    Pengfei Li
    Yihong Zhan
    Huanjie Shao
    Cell & Bioscience, 7